<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02926911</url>
  </required_header>
  <id_info>
    <org_study_id>AFT-25</org_study_id>
    <nct_id>NCT02926911</nct_id>
  </id_info>
  <brief_title>Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS</brief_title>
  <acronym>COMET</acronym>
  <official_title>Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS: A Phase III Prospective Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alliance Foundation Trials, LLC.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dana-Farber Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>New York University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Alliance Foundation Trials, LLC.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study looks at the risks and benefits of active surveillance (AS) compared to guideline
      concordant care (GCC) in the setting of a pragmatic prospective randomized trial for low risk
      DCIS. Our overarching hypothesis is that management of low-risk Ductal Carcinoma in Situ
      (DCIS) using an AS approach does not yield inferior cancer or quality of life outcomes
      compared to GCC.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Overdiagnosis and overtreatment resulting from mammographic screening have been estimated to
      be as high as 1 in 4 patients diagnosed with breast cancer although the absence of standard
      definitions for measuring overdiagnosis has led to much uncertainty around this estimate. The
      national health care expenditure resulting from false positive mammograms and breast cancer
      overdiagnosis has been estimated to approach $4 billion annually. There is general consensus
      that much of this burden derives from the treatment of DCIS; for those estimated 40,000 women
      per year whose DCIS may never have progressed even without treatment, medical intervention
      can only harm. In those women who undergo surgical management of DCIS, there is risk of
      developing persistent pain at the surgical site, with estimates ranging from 25-68%.
      Importantly, persistent pain after lumpectomy may be as prevalent as that after total
      mastectomy. Persistent postsurgical pain is rated by patients as the most troubling symptom,
      leading to disability and psychological distress, and is often resistant to management.
      Although prospective population-based data have demonstrated significant patient and surgical
      focus on pain with remarkably high levels of chronic pain 4 and 9 months after breast
      surgery, much of these data have been collected in women with invasive cancer, with little
      data directly relevant to patients with DCIS.

      The overarching hypothesis of the study is that management of low-risk DCIS using an active
      surveillance (AS) approach does not yield inferior cancer or quality of life outcomes
      compared to guideline concordant care (GCC).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 22, 2017</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of new diagnoses of ipsilateral invasive cancer in GCC and AS arms at 2 years of follow up</measure>
    <time_frame>At 2 years follow-up</time_frame>
    <description>To compare the number of patients that develop ipsilateral invasive cancer that received guidance concordant care to the number of patients that were placed on active surveillance after 2 years of follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (QOL)</measure>
    <time_frame>Baseline, 6 months, 1 year, and once a year (years 2 through 5)</time_frame>
    <description>Measured by Short Form (SF)-36</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological outcomes</measure>
    <time_frame>Baseline, 6 months, 1 year, and once a year (years 2 through 5)</time_frame>
    <description>Measured by five dimensions questionnaire (EQ-5D)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generalized anxiety</measure>
    <time_frame>Baseline, 6 months, 1 year, and once a year (years 2 through 5)</time_frame>
    <description>Measured by the State Trait Anxiety Inventory (STAI) scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generalized Depression</measure>
    <time_frame>Baseline, 6 months, 1 year, and once a year (years 2 through 5)</time_frame>
    <description>Measured by the Center for Epidemiologic Studies Depression Scale (CES-D) 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coping</measure>
    <time_frame>Baseline</time_frame>
    <description>Coping evaluated using the Brief COPE, a shortened form of the COPE Inventory, inclusive of 28 items (14 subscales).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intolerance of uncertainty</measure>
    <time_frame>Baseline and at 2 years</time_frame>
    <description>Assessment of feelings of uncertainty using the Intolerance of Uncertainty Scale (Short-form), which has been used in studies of active surveillance in the prostate cancer setting.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mastectomy rate</measure>
    <time_frame>2, 5, and 7 year follow-up</time_frame>
    <description>To compare the impact of GCC vs. AS on the number of mastectomies performed in patients with DCIS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breast conservation rate</measure>
    <time_frame>2, 5, and 7 year follow-up</time_frame>
    <description>To compare the impact of GCC vs. AS on the number of breast conservation surgeries performed in patients with DCIS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contralateral invasive cancer rate</measure>
    <time_frame>2, 5, and 7 year follow-up</time_frame>
    <description>To compare the impact of GCC vs. AS on the rate of development of contralateral invasive cancer in patients with DCIS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival rate</measure>
    <time_frame>2, 5, and 7 year follow-up</time_frame>
    <description>To compare the impact of GCC vs. AS on the overall survival rate in patients with DCIS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breast cancer specific survival rate</measure>
    <time_frame>2, 5, and 7 year follow-up</time_frame>
    <description>To compare the impact of GCC vs. AS on the breast cancer specific survival rate in patients with DCIS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ipsilateral invasive cancer rate in GCC arm at 5 and 7 year follow-up</measure>
    <time_frame>5 and 7 year follow-up</time_frame>
    <description>To determine the number of DCIS patients in the GCC arm that develop ipsilateral invasive cancer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ipsilateral invasive cancer rate in AS arm</measure>
    <time_frame>5 and 7 year follow-up</time_frame>
    <description>To determine the number of DCIS patients in the AS arm that develop ipsilateral invasive cancer</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Breast MRI utilization rate</measure>
    <time_frame>2, 5, and 7 year follow-up</time_frame>
    <description>Determine the rate of use of breast MRI imaging compared to use of other breast imaging techniques</description>
  </other_outcome>
  <other_outcome>
    <measure>Breast biopsy rate</measure>
    <time_frame>2, 5, and 7 year follow-up</time_frame>
    <description>Determine the rate of biopsies performed during follow-up of patients with DCIS</description>
  </other_outcome>
  <other_outcome>
    <measure>Radiation rate</measure>
    <time_frame>2, 5, and 7 year follow-up</time_frame>
    <description>Determine the rate of the performance of radiation therapy on patients with DCIS</description>
  </other_outcome>
  <other_outcome>
    <measure>Chemotherapy rate</measure>
    <time_frame>2, 5, and 7 year follow-up</time_frame>
    <description>Determine the rate of the use of chemotherapy on patients with DCIS</description>
  </other_outcome>
  <other_outcome>
    <measure>Self-reported co-morbidity</measure>
    <time_frame>6 months, 1 year, and once a year (years 2 through 5)</time_frame>
    <description>Self-reported diary</description>
  </other_outcome>
  <other_outcome>
    <measure>Adherence to hormonal therapy</measure>
    <time_frame>6 months, 1 year, and once a year (years 2 through 5)</time_frame>
    <description>Evaluated with a drug diary</description>
  </other_outcome>
  <other_outcome>
    <measure>Symptoms</measure>
    <time_frame>Baseline, 6 months, 1 year, and once a year (years 2 through 5)</time_frame>
    <description>A modified 19-item version of the Breast Cancer Prevention Trial (BCPT) Symptom Checklist will evaluate commonly reported menopausal symptoms</description>
  </other_outcome>
  <other_outcome>
    <measure>General pain</measure>
    <time_frame>Baseline, 6 months, 1 year, and once a year (years 2 through 5)</time_frame>
    <description>Evaluated with the Brief Pain Inventory, a well-validated general measure of pain and disability worst pain, least pain, and interference</description>
  </other_outcome>
  <other_outcome>
    <measure>Breast specific pain</measure>
    <time_frame>Baseline, 6 months, 1 year, and once a year (years 2 through 5)</time_frame>
    <description>Breast specific pain will be measured by the Breast Cancer Pain Questionnaire (BCPQ); the BCPQ includes assessment of pain severity, pain frequency (how many days/week), and pain location (breast, arm, side, axilla), from which a Pain Burden Index (PBI) can be calculated</description>
  </other_outcome>
  <other_outcome>
    <measure>Body image</measure>
    <time_frame>Baseline, 6 months, 1 year, and once a year (years 2 through 5)</time_frame>
    <description>Body image will be evaluated by the Breast-Questionnaire, a validated instrument to evaluate outcomes following surgery, will be used to evaluate satisfaction with body image</description>
  </other_outcome>
  <other_outcome>
    <measure>Decisional regret</measure>
    <time_frame>Years 1 through 5</time_frame>
    <description>The Decision Regret Scale will measure how women perceived their DCIS treatment decision. The SURE scale, which is composed of four items from the Decisional Conflict Scale will be used to measure patients' uncertainty about which treatment to choose and factors contributing to uncertainty (feeling uninformed, unclear values, and unsupported in decision-making).</description>
  </other_outcome>
  <other_outcome>
    <measure>Knowledge</measure>
    <time_frame>Baseline and 2 years</time_frame>
    <description>DCIS and breast cancer knowledge will be measured with items adapted from the Breast Cancer Surgery Decision Quality Instrument (BCS-DQI) as well as questions developed specifically for a study that assessed DCIS knowledge and risk perceptions. The investigators will assess risk perceptions in women with DCIS using questions developed by Lerman and Croyle that will measure risk perceptions in relation to psychosocial outcomes in women with DCIS</description>
  </other_outcome>
  <other_outcome>
    <measure>Risk perceptions</measure>
    <time_frame>Baseline and 2 years</time_frame>
    <description>Measured by the Breast Cancer Surgery Decision Quality Instrument (BCS-DQI)</description>
  </other_outcome>
  <other_outcome>
    <measure>Communication with physicians</measure>
    <time_frame>Baseline</time_frame>
    <description>To assess communication with physicians about DCIS management options, the investigators will adapt items used in a prior study of surgical decision-making, including the extent to which their physician talked to them about AS vs. GCC. Additionally the investigators will ask about sources of information for the management of their DCIS</description>
  </other_outcome>
  <other_outcome>
    <measure>Financial burden</measure>
    <time_frame>6 months</time_frame>
    <description>The investigators will adapt items from the National Health Interview Survey and the Cancer Outcomes Research and Surveillance (CanCORS) Study to assess financial burden. The investigators will also ask women to Cancer Care estimate out of pocket expenses attributed to their DCIS diagnosis.</description>
  </other_outcome>
  <other_outcome>
    <measure>Employment status</measure>
    <time_frame>Baseline, 6 months, year 1, and once a year (years 1 through 5)</time_frame>
    <description>Employment status will be assessed using a measure that is being added to the Alliance Patient Questionnaire as it has been tested and validated in breast cancer populations.</description>
  </other_outcome>
  <other_outcome>
    <measure>Concerns about future breast events</measure>
    <time_frame>Baseline and 2 years</time_frame>
    <description>Four items from the Quality of Life in Adult Cancer Survivors (QLACS) scale will be adapted to evaluate frequency (1=never; 7=always) of worries about DCIS, including concerns about future breast events and death from DCIS</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>DCIS</condition>
  <condition>Ductal Carcinoma in Situ</condition>
  <arm_group>
    <arm_group_label>Guideline Concordant Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>DCIS - Surgery +/- radiation choice for endocrine therapy (MMG q 12 months x 5 years usual care for recurrent disease)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active Surveillance</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DCIS - Choice for endocrine therapy (MMG q 6 months x 5 years GCC for invasive progression)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Guideline Concordant Care</intervention_name>
    <description>Surgery +/- radiation choice for endocrine therapy</description>
    <arm_group_label>Guideline Concordant Care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Active Surveillance</intervention_name>
    <description>Choice for endocrine therapy</description>
    <arm_group_label>Active Surveillance</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  New diagnosis of DCIS without invasive cancer; date of diagnosis defined as the date
             of the first pathology report that diagnosed the patient with DCIS

          -  Unilateral, bilateral, unifocal, or multifocal DCIS

          -  ADH/borderline DCIS

          -  A patient who has had a lumpectomy with positive margins as part of their treatment
             for a current DCIS diagnosis is eligible (post-excision mammogram required at
             enrollment to establish a new baseline)

          -  No previous history of breast cancer (DCIS or invasive cancer) in either breast prior
             to current DCIS diagnosis

          -  40 years of age or older at time of DCIS diagnosis

          -  ECOG performance status 0 or 1

          -  No contraindication for surgery

          -  Baseline imaging:

               -  Unilateral DCIS: contralateral normal mammogram ≤ 6 months of registration and
                  ipsilateral breast imaging ≤ 90 days of registration (must include ipsilateral
                  mammogram; can also include ultrasound or breast MRI)

               -  Bilateral DCIS: bilateral breast imaging ≤ 90 days of registration (must include
                  bilateral mammogram; can also include ultrasound or breast MRI)

          -  Pathologic criteria:

               -  Any grade I DCIS

               -  Any grade II DCIS without comedonecrosis

               -  Absence of invasion or microinvasion

               -  Diagnosis confirmed on core needle, vacuum-assisted or surgery ≤ 90 days of
                  registration

               -  ER(+) and/or PR(+) by IHC (≥ 10% staining or Allred score ≥ 4)

               -  HER2 0, 1+, or 2+ by IHC if HER2 testing is performed

          -  Histology slides reviewed and agreement between two clinical pathologists (not
             required to be at same institution) that pathology fulfills COMET eligibility
             criteria. In cases of disagreement between the two pathology reviews about whether or
             not a case fulfills the eligibility criteria, a third pathology review will be
             required.

          -  At least two sites of biopsy for those cases where mammographic extent of
             calcifications exceeds 4 cm, with second biopsy benign or both sites fulfilling
             pathology eligibility criteria

          -  Amenable to follow up examinations

          -  Ability to read, understand and evaluate study materials and willingness to sign a
             written informed consent document

          -  Reads and speaks Spanish or English

        Exclusion Criteria:

          -  Male DCIS

          -  Grade II DCIS with comedonecrosis

          -  Papillary or micropapillary DCIS

          -  Concurrent diagnosis of invasive or microinvasive breast cancer in either breast

          -  Documented mass on examination or imaging at site of DCIS prior to biopsy yielding
             diagnosis of DCIS, with exception of fibroadenoma at a distinct/separate site from
             site of DCIS. In cases of uncertainty about whether the mass was present on physical
             examination prior to biopsy, the following criteria should be applied: if mammogram
             noting abnormal findings is diagnostic MMG = symptomatic/if mammogram noting abnormal
             findings is screening MMG = asymptomatic

          -  Bloody nipple discharge

          -  Mammographic finding of BIRADS 4 or greater within 6 months of registration at site
             other than that of known DCIS, without pathologic assessment

          -  Use of investigational cancer agents within 6 weeks prior to diagnosis

          -  Any serious and/or unstable pre-existing medical, psychiatric, or other existing
             condition that would prevent compliance with the trial or consent process

          -  Pregnancy. If a woman has been confirmed as pregnant she will not be eligible to take
             part in the trial. If she suspects there is a chance that she may be pregnant, a
             pregnancy test should be undertaken; however, a pregnancy test for all women of
             child-bearing potential is not mandatory

          -  Documented history of prior tamoxifen, aromatase inhibitor, or raloxifene in last 6
             months
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shelley Hwang, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ann Partridge, MD, MPH</last_name>
    <role>Study Chair</role>
    <affiliation>Dana-Farber Cancer Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alastair Thompson, MD</last_name>
    <role>Study Chair</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Lynch, PhD</last_name>
    <phone>(443) 286-4595</phone>
    <email>thomas.lynch2@duke.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shelley Hwang, MD, MPH</last_name>
    <phone>(919) 684-6849</phone>
    <email>shelley.hwang@duke.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Providence Alaska Medical Center</name>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <zip>99508</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeanne Anderson, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Armando Giuliano, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sharp Memorial Hospital</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reema Batra, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Colorado Cancer Research Program</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80222</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keren Sturtz, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Boisvert, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Hawaii Cancer Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenneth Sumida, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kootenai Health</name>
      <address>
        <city>Post Falls</city>
        <state>Idaho</state>
        <zip>83854</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Marchello, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>NorthShore University HealthSystem-Evanston Hospital</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katharin Yao, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Indiana University Health Melvin and Bren Simon Cancer Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samillia Obeng-Gyasi, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Elizabeth Healthcare Edgewood</name>
      <address>
        <city>Edgewood</city>
        <state>Kentucky</state>
        <zip>41017</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J.Mike Guenther, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ochsner Medical Center Jefferson</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aimee Mackey, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Eastern Maine Medical Center Cancer Care</name>
      <address>
        <city>Brewer</city>
        <state>Maine</state>
        <zip>04412</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Sinclair, DO</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maine Center for Cancer Medicine-Scarborough</name>
      <address>
        <city>Scarborough</city>
        <state>Maine</state>
        <zip>04074</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chiara Battelli, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Anne Arundel Medical Center</name>
      <address>
        <city>Annapolis</city>
        <state>Maryland</state>
        <zip>21401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wen Liang, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dana-Farber Cancer Institute</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mehra Golshan, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Mercy Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48197</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip Stella, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Metro MN Community Oncology Research Consortium (MMCORC)</name>
      <address>
        <city>Saint Louis Park</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michaela Tsai, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Community Hospital of Anaconda</name>
      <address>
        <city>Anaconda</city>
        <state>Montana</state>
        <zip>59711</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Marchmello, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Billings Clinic</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Marchello, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bozeman Health</name>
      <address>
        <city>Bozeman</city>
        <state>Montana</state>
        <zip>59715</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Marchello, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Benefis Sletten Cancer Institute</name>
      <address>
        <city>Great Falls</city>
        <state>Montana</state>
        <zip>59405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Marchello, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kalispell Regional Medical Center</name>
      <address>
        <city>Kalispell</city>
        <state>Montana</state>
        <zip>59901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Marchello, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Community Medical Center</name>
      <address>
        <city>Missoula</city>
        <state>Montana</state>
        <zip>59804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Marchello, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Carson Tahoe Health</name>
      <address>
        <city>Carson City</city>
        <state>Nevada</state>
        <zip>89703</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dina Tack, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>New Hampshire Oncology Hematology PA</name>
      <address>
        <city>Hooksett</city>
        <state>New Hampshire</state>
        <zip>03106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Douglas Weckstein, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Englewood Hospital and Medical Center</name>
      <address>
        <city>Englewood</city>
        <state>New Jersey</state>
        <zip>07631</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Violet M McIntosh, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tara Balija, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>New Mexico Cancer Care Alliance</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Fine, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Roswell Park Cancer Institute</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14263</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ellis Levine, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>60608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hank Schmidt, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stony Brook Medical Center</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brain O'Hea, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>State University of New York Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Lai, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oluwadamilola Fayanju, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Southeastern Medical Oncology Center</name>
      <address>
        <city>Goldsboro</city>
        <state>North Carolina</state>
        <zip>27534</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Atkins, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cone Health Cancer Center</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vinay Gudena, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>East Carolina University</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Wong, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rex Cancer Center</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henry Cromartie, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Health</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Akiko Chiba, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Strecker Cancer Center - Belpre</name>
      <address>
        <city>Belpre</city>
        <state>Ohio</state>
        <zip>45714</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Moore, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ohio State University Comprehensive Cancer Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Doreen Agnese, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ohio State University Comprehensive Cancer Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Doreen Agnese, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Carmel East Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Moore, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbus Oncology &amp; Hematology INC</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Moore, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Riverside Methodist Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Moore, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Grant Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Moore, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MidOhio Oncology Hematology, Mark H. Zangmeister Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Moore, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Carmel West Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43223</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Moore, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Doctors Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43228</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Moore, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Grady Hospital</name>
      <address>
        <city>Delaware</city>
        <state>Ohio</state>
        <zip>43015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Moore, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>OhioHealth Grady - Delaware Health Center</name>
      <address>
        <city>Delaware</city>
        <state>Ohio</state>
        <zip>43015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Moore, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>OhioHealth Mansfield Hospital</name>
      <address>
        <city>Mansfield</city>
        <state>Ohio</state>
        <zip>44903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Moore, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Marietta Memorial Hospital</name>
      <address>
        <city>Marietta</city>
        <state>Ohio</state>
        <zip>45750</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Moore, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>OhioHealth Marion General Hospital</name>
      <address>
        <city>Marion</city>
        <state>Ohio</state>
        <zip>43302</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Moore, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Licking Memorial Hospital</name>
      <address>
        <city>Newark</city>
        <state>Ohio</state>
        <zip>43055</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Moore, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Ann's Hospital</name>
      <address>
        <city>Westerville</city>
        <state>Ohio</state>
        <zip>43081</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Moore, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Genesis Health Care System</name>
      <address>
        <city>Zanesville</city>
        <state>Ohio</state>
        <zip>43701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Moore, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Centers of Southwest Oklahoma</name>
      <address>
        <city>Lawton</city>
        <state>Oklahoma</state>
        <zip>73505</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Najera, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Charles Health System</name>
      <address>
        <city>Bend</city>
        <state>Oregon</state>
        <zip>97701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Boone, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Magee-Womens Hospital of UPMC</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Priscilla McAuliffe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy DeMore, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UT Southwestern/Simmons Cancer Center-Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marilyn Leitch, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>60586</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alastair Thompson, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Huntsman Cancer Institute</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy Matsen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sentara Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric C. Feliberti, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Overlake Hospital Medical Center</name>
      <address>
        <city>Bellevue</city>
        <state>Washington</state>
        <zip>98004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristi Harrington, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Health Care, Aurora Cancer Care</name>
      <address>
        <city>Burlington</city>
        <state>Wisconsin</state>
        <zip>53105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Tjoe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Health Center - Fond du Lac</name>
      <address>
        <city>Fond Du Lac</city>
        <state>Wisconsin</state>
        <zip>54937</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Tjoe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Health Care, Germantown Health Center</name>
      <address>
        <city>Germantown</city>
        <state>Wisconsin</state>
        <zip>53022</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Tjoe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Health Care, Aurora Cancer Care</name>
      <address>
        <city>Grafton</city>
        <state>Wisconsin</state>
        <zip>53024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Tjoe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>BayCare Aurora LLC, Aurora Cancer Care</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54311</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Tjoe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Health Care, Aurora Cancer Care</name>
      <address>
        <city>Kenosha</city>
        <state>Wisconsin</state>
        <zip>49408</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Tjoe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Bay Area Medical Group - Cancer Care Clinic</name>
      <address>
        <city>Marinette</city>
        <state>Wisconsin</state>
        <zip>54143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Tjoe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Health Care, Aurora Cancer Care</name>
      <address>
        <city>Marinette</city>
        <state>Wisconsin</state>
        <zip>54143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Tjoe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Health Care, Aurora Cancer Care</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Tjoe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vince Lombardi Cancer Clinic of Aurora St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Tjoe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Froedtert and the Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tina Yen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Health Care, Aurora Cancer Care</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Tjoe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Health Care, Aurora Cancer Care</name>
      <address>
        <city>Oshkosh</city>
        <state>Wisconsin</state>
        <zip>54904</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Tjoe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Health Care, Aurora Cancer Care</name>
      <address>
        <city>Racine</city>
        <state>Wisconsin</state>
        <zip>53406</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Tjoe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Health Care, Aurora Cancer Care</name>
      <address>
        <city>Sheboygan</city>
        <state>Wisconsin</state>
        <zip>53081</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Tjoe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Health Care, Aurora Cancer Care</name>
      <address>
        <city>Summit</city>
        <state>Wisconsin</state>
        <zip>53066</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Tjoe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Health Care, Aurora Cancer Care</name>
      <address>
        <city>Two Rivers</city>
        <state>Wisconsin</state>
        <zip>54241</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Tjoe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Health Care, Aurora Cancer Care</name>
      <address>
        <city>Wauwatosa</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Tjoe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Health Care, Aurora Cancer Care</name>
      <address>
        <city>West Allis</city>
        <state>Wisconsin</state>
        <zip>53227</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Tjoe, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, Yankaskas BC, Rosenberg R, Carney PA, Kerlikowske K, Taplin SH, Urban N, Geller BM. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002 Oct 16;94(20):1546-54.</citation>
    <PMID>12381707</PMID>
  </reference>
  <reference>
    <citation>Erbas B, Provenzano E, Armes J, Gertig D. The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat. 2006 May;97(2):135-44. Epub 2005 Dec 1. Review.</citation>
    <PMID>16319971</PMID>
  </reference>
  <reference>
    <citation>Ozanne EM, Shieh Y, Barnes J, Bouzan C, Hwang ES, Esserman LJ. Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat. 2011 Aug;129(1):165-73. doi: 10.1007/s10549-011-1430-5. Epub 2011 Mar 9.</citation>
    <PMID>21390494</PMID>
  </reference>
  <reference>
    <citation>Nyström L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Rydén S, Andersson I, Bjurstam N, Fagerberg G, Frisell J, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet. 1993 Apr 17;341(8851):973-8. Erratum in: Lancet 1993 Nov 27;342(8883):1372.</citation>
    <PMID>8096941</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 19, 2016</study_first_submitted>
  <study_first_submitted_qc>October 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2016</study_first_posted>
  <last_update_submitted>April 11, 2018</last_update_submitted>
  <last_update_submitted_qc>April 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ductal Carcinoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma in Situ</mesh_term>
    <mesh_term>Carcinoma, Ductal</mesh_term>
    <mesh_term>Carcinoma, Intraductal, Noninfiltrating</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Patient medical information both, associated with biologic specimens or not, is confidential and may only be disclosed to third parties as permitted by the Informed Consent Form (ICF) (or separate authorization for use and disclosure of personal health information) which has been signed by the patient, unless permitted or required by law. Data derived from biologic specimen analysis on individual patients will in generally not be provided to study investigators unless a request for research use is granted. The overall results of any research conducted using biologic specimens will be available in accordance with the effective Alliance Foundation Trial (AFT) policy on study data publication.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

